Understanding obesity and diabetes through mouse models
Official title: Yale Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
Funded at Yale University · NIH-11016917 · Data updated 2026-11-12
This study is all about helping scientists learn more about obesity and diabetes by looking closely at mice, which can help improve treatments for people with these conditions in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | February 1, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $686,631 |
| NIH project number | 5U2CDK134901-03 |
| Project ID | NIH-11016917 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals affected by obesity or diabetes, as well as those interested in the genetic factors influencing these conditions.
✕Less likely to help
Patients who do not have obesity or diabetes, or those not interested in genetic research, may not receive direct benefits from this research.
What this research studies
This research focuses on providing scientists with access to advanced metabolic phenotyping services to study mouse models of obesity and diabetes. By utilizing mouse genetics, the project aims to characterize metabolic changes associated with these conditions. The research involves collaboration among various cores that facilitate the screening, monitoring, and phenotyping of mice, ensuring a comprehensive approach to understanding complex metabolic diseases. Patients may benefit indirectly through advancements in treatments derived from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for obesity and diabetes.
How similar studies have gone: Previous research has shown success in using similar metabolic phenotyping approaches to understand obesity and diabetes.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Shulman, Gerald I — Yale University
- Study coordinator: Shulman, Gerald I
Related research
Other NIH-funded projects on the same topics.
-
Ethical Multimodal AI for Obesity, Diabetes and Digestive Disease
A Penn team is building safe, multimodal AI tools using medical data to help care for obesity, diabetes, and digestive diseases.
-
DHRS9's role in diet-induced obesity and diabetes
A study investigates how DHRS9 affects obesity-related diabetes in mice, to understand whether vitamin A or inflammatory lipid signals drive insulin resistance.
-
Ksr2 and obesity-related hearing loss in a mouse model: what it means for veterans
This project studies how obesity and type 2 diabetes affect hearing using a mouse model to identify ways to protect hearing in people with metabolic problems.
-
Low-cost, heat-stable GLP-1 and GIP receptor agonists produced in maize for diabetes and obesity
This project aims to make affordable, heat-stable versions of diabetes and obesity medicines using corn plants.
-
Epitranscriptomics in obesity and type 2 diabetes
Researchers are studying how gene activity changes in fat tissue and other organs to better understand obesity and type 2 diabetes, with the goal of finding new ideas for treatment.
-
LAUNCHED: Advancing early-career scientists in health, nutrition, obesity, and diabetes research
A national program helps new researchers in diabetes and related digestive diseases build careers through mentoring, training, and funding support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.